New Delhi: Dispovan syringe fame Hindustan Syringes & Medical Devices (HMD), one of the largest manufacturers Disposable Syringes in the World and the largest for Auto Disable syringes, has rendered yet another international grade device Insulin Pen Needle all set to puncture the monopoly of an American medical device behemoth.
Dispovan Insulin Pen Needle, which was launched on May 25 in Medical Expo Indore 2018, is first ‘Made in India’ insulin pen needle. The upshot is; this single use insulin needle will lessen the pain to a great extent.
The Dispovan Insulin pen needle is a precision engineered, yet affordable sterile single use pen needle, which can be universally fitted on all international brands of Insulin Pens. With features like, ergonomic shape for improved skin contact and grip, extra thin wall, multi-bevel, tapered point, Dispovan Insulin pen needle is designed and manufactured by HMD with intent to offer a much less painful injection experience for diabetic patients.
In his missive sent to Medicare News, Mr.Rajiv Nath, Jt.Managing Director of Hindustan Syringes & Medical Devices (HMD), said, ‘ We are particularly excited about the prospects of our latest offering Dispovan Insulin Pen Needle” manufactured in our state of the art manufacturing facilities, which will end India’s import dependency and the monopoly of BD. We have received excellent feedback and clinical acceptance from the end users of a comfortable injection and glad that our investments in high end technology are giving us a competitive edge.’
‘With the launch of ‘Dispovan Insulin Pen Needle’, we will contribute towards our ongoing commitment of making healthcare affordable for common people in India’ said Mr.Pardeep Sareen, Chief General Manager-Marketing of HMD. He quipped, ‘Why reuse a pen needle when Dispovan makes it affordable for single use?
Reuse of a Insulin pen needle could increase the risk of bacterial growth on the needle, pain when injected, of lipohypertrophy (lumpy skin) and risk of t very fine tip of the needle breaking off. These risks grow with each re-use.
Dispovan Insulin Pen Needle is being manufactured at HMD’s Faridabad-Ballabgarh plant. The new plant is spread on an area of 5.5 acres and will have the capacity to initially produce over 100 million units per annum of ‘Dispovan Insulin Pen Needle’ to meet the rising export and domestic demand for its new technology. Every Needle point is checked online by a Digital Vision Camera System for a defective, blunt needle point and such needles, which can be potentially painful, are rejected automatically on line. The proprietary dry silicon coating used by us makes the needle surface slippery to ensure comfortable injection.
The pricing of the Becton, Dickinson and Company (BD) pen needle is Rs.14 MRP whereas HMD has initially kept its MRP at Rs.12. Dispovan pen needle is economical to patient by at least 15 %, as compared to imported pen needles.
